Database on National Social Welfare Policies for Survivors and Victims of Nazi Persecution

The Database on National Social Welfare Policies for Survivors and Victims of Nazi Persecution was supported in its creation by the European Shoah Legacy Institute and presented at the International Conference on Welfare for Holocaust Survivors and Other Victims of Nazi Persecution on May 26-27, 2015 in Prague, Czech Republic.
As stated in the Project Report, the purpose of the database is to provide governments, advocacy groups and international institutions important information about the progress of Terezin Declaration countries in achieving their commitments to ensure that the social welfare needs of Holocaust survivors and other victims of Nazi persecution are met, and that these individuals are able to live the remainder of their lives with dignity.
This database serve to provide information for academics, policymakers and other interested individuals.For further information and queries about any information listed here, please contact us.

Please find the country you seek either on the map or scroll down below for countries listed alphabetically.

Country Has Data No Data Available

Switzerland

9,50

No further details

6,70

No further details

$54 983

Details: PPP constant 2011 international $

530

No further details

yes

No further details

0,00%

No further details

mixed

Details: In principle, adjustment every two years to the development of wages and prices. Early adjustment when the consumer price index has increased by more than 4% in one year.

EUR 875

No further details

5

No further details

subjective right

No further details

no

No further details

included in social assistance

No further details

included in social assistance

No further details

0

Details:

0

Details:

no

Details:

no

Details:

yes

No further details

25,90%

No further details

11,50%

No further details

private compulsory

No further details

reimbursement

No further details

0

No further details

no

No further details

yes

Details: Fixed amount per calendar year (excess, deductible, “franchise”): CHF 300 (€247). In addition, share of costs: 10% of costs above the excess up to CHF 700 (€576) per year. The insurer may offer the insured person a form of insurance with a higher excess - CHF 500 (€411), CHF 1,000 (€822), CHF 1,500 (€1,233), CHF 2,000 (€1,644) or CHF 2,500 (€2,056) for adults, CHF 100 (€82), CHF 200 (€164), CHF 300 (€247), CHF 400 (€329), CHF 500 (€411) or CHF 600 (€493) for children (< 18 years) - in return for a reduction in the premium. In addition, a contribution to the costs of board and accommodation of CHF 15 (€12) per day.

yes

Details: The beneficiaries of supplementary benefits to old-age, survivors' and invalidity insurance (non-contributory benefits subject to means testing) are reimbursed for the costs of participation referred to in the KVG/LAMal (up to a ceiling).

private compulsory

No further details

reimbursement

No further details

0

No further details

no

No further details

yes

Details: Fixed amount per calendar year (excess, deductible, “franchise”): CHF 300 (€247). In addition, share of costs: 10% of costs above the excess up to CHF 700 (€576) per year. The insurer may offer the insured person a form of insurance with a higher excess - CHF 500 (€411), CHF 1,000 (€822), CHF 1,500 (€1,233), CHF 2,000 (€1,644) or CHF 2,500 (€2,056) for adults, CHF 100 (€82), CHF 200 (€164), CHF 300 (€247), CHF 400 (€329), CHF 500 (€411) or CHF 600 (€493) for children (< 18 years) - in return for a reduction in the premium.

yes

Details: The beneficiaries of supplementary benefits to old-age, survivors' and invalidity insurance (non-contributory benefits subject to means testing) are reimbursed for the costs of participation referred to in the KVG/LAMal (up to a ceiling).

private voluntary

No further details

reimbursement

No further details

yes

Details: full cost except for very serious dental problems or those caused by other conditions

yes

Details: For listed drugs: Same participation as for medical care (however share of costs of 20% for drugs whose price exceeds by more than 20% the average price of the cheapest third of the drugs with the same active substance).

yes

No further details

no

Details: paid by first tier invalidity insurance

no

No further details

yes

Details: not covered

no

Details: reduced only for children

yes

No further details

no

Details: covered by invalidity insurance

no

No further details

yes

Details:

yes

No further details

6,00%

No further details

13,00%

No further details